Global Congress on Pharmaceutical Sciences and Clinical Research on April 23-25, 2024 in Singapore, Singapore

WELCOME REMARK

On behalf of the Organizing Committee, it is our great pleasure to welcome you to the 3rd Global Congress on Pharmaceutical Sciences and Clinical Research (PSCR 2024), which will be held during Apr. 23rd-25th, 2024 in Singapore with hybrid format.

Main topics of the program include: Pharmacology and Pharmacogenomics, Pharmaceutical Innovation, Pharmaceutical Biology and Medical Chemistry, Pharmaceutics and Drug Delivery, Drug Development and Analytical Technologies, Targets and Drug Design, Small Molecules Drugs, Cancers and Tumors, Neurodegenerative and Mental Diseases, Respiratory Diseases and Asthma, Antimicrobial and Antiviral Agents, Antibody and Vaccines, Inflammation and Immunology, Natural Products and Traditional Therapy, Laws, Regulations, Policies and Market Trends.

PSCR 2024 brings together the best scientists from universities, research institutes and the pharmaceutical industry worldwide to share exciting results and to build new collaborations.

We believe you will find the conference as well as your visit to Singapore both valuable and enjoyable.

Website: https://pscr2024.lmsii.org/; https://pscr2024.vowcongress.cn/

Contact us: Ms. Elsa Chien Email: [email protected]

Topics:

Pharmaceutical Innovation;

Small Molecules Drugs;

Targets and Drug Design;

Pharmaceutics and Drug Delivery;

Pharmacology and Pharmacogenomics;

Natural Products and Traditional Therapy;

Pharmaceutical Biology and Medical Chemistry;

Drug Development and Analytical Technologies

Renowned Speakers of PSCR 2024

Dr. Alexandros Makriyannis, Northeastern University, USA;

Dr. Ewoud-Jan van Hoogdalem, ICON, Ireland;

Dr. Rimma Shaginian, Care Holdings AG, Switzerland;

Dr. Constantine S. Mitsiades, Dana-Farber Cancer Institute, USA;

Dr. Virgil Stenberg, University of North Dakota, USA;

Dr. Levon M. Khachigian, University of New South Wales, Australia;

Dr. Shawn Shouye Wang, WuXi XDC, USA;

Dr. Tudor Arvinte, Therapeomic Inc., Switzerland;

Dr. Salvatore Condello, Indiana University School of Medicine, USA

Organizing Committee

Hosting Organization

Life and Medical Sciences Innovation Institute(LMSII)

Operating Organization

Amazing Congress Co. LTD.

VOW Congress Inc.

Conference Coordinator

Ms. Elsa Hsieh

Scientific Committee Members

Dr. Pedro Fonte, Assistant Professor, University of Algarve, Portugal

Dr. Levon M Khachigian, Professor, University of New South Wales, Australia

Dr. Dae Wook Lee, Medical Director, Novartis Korea, South Korea

Prof. Donald W. Light, Professor, Rowan University, USA

Dr. Ayman M. Mahmoud, Assistant Professor, Beni-Suef University, Egypt

Dr. Luca Roncati, Professor, University Hospital of Modena, University of Modena and Reggio Emilia, Italy

Dr. Dinender K. Singla, Professor of Medicine, University of Central Florida, USA

Dr. Vetriselvan Subramaniyan, Deputy Dean, MAHSA University, Malaysia

Schedule of SWCR & CMB & PSCR 2024

Based upon GMT+8, Singapore Time

Apr. 22, 2024 (Monday)

8:30-12:00

CMB Hybrid Session: Genetics & Genomics

CMB Hybrid Session: Protein, Peptide and Proteomics

SWCR Hybrid Session: Case Studies/Clinical Experience

13:30-18:30

SWCR Hybrid Session: Cancer Biomarker and Diagnosis

SWCR Hybrid Session: Cancer Genetics and Genomics

CMB Hybrid Session: Breaking Research in Cell Biology

CMB Hybrid Session: Molecular Diagnostics & Biomarkers

20:30-22:00

SWCR Online Session: Plenary Forum of SWCR

Apr. 23, 2024 (Tuesday)

8:30-12:00

PSCR Hybrid Session: Cancers and Tumors

SWCR Hybrid Session: Cancer Cell and Molecular Biology

SWCR Hybrid Session: Tumor Microenvironment

CMB Hybrid Session: Signaling Pathways and Therapeutic Targets

13:30-18:30

PSCR Hybrid Session: Plenary Forum of PSCR

CMB Hybrid Session: Advances in DNA & RNA Research

SWCR Hybrid Session: New Therapeutics and Targets

SWCR Hybrid Session: Liver Cancer and Pancreatic Cancers

20:30-22:00

SWCR Online Session: Cancer Informatics and Precision Oncology

Apr. 24, 2024 (Wednesday)

8:30-12:00

SWCR Hybrid Session: Cancer Therapy and Treatment (Part 1)

PSCR Hybrid Session: Antibody and Vaccines

13:30-18:30

SWCR Hybrid Session: Lung Cancer

SWCR Hybrid Session: Immunology and Immunotherapy

CMB Hybrid Session: Biomaterials and Biological Engineering

PSCR Hybrid Session: Metabolic and Endocrine Disorders

20:30 -22:00

SWCR Online Session: Cancer Therapy and Treatment (Part 2)

Apr. 25, 2024 (Thursday)

8:30-12:00

PSCR Hybrid Session: Small Molecule Antagonists and Agonists

PSCR Hybrid Session: Infectious Diseases

PSCR Hybrid Session: Natural Products and Traditional Therapy

13:30-18:30

PSCR Hybrid Session: Inflammation and Immunology

PSCR Hybrid Session: Pharmacology and Pharmacogenomics

PSCR Hybrid Session: Pharmaceutics and Drug Delivery

PSCR Hybrid Session: Pharmaceutical Biology and Medical Chemistry